TRV-7019
TRV-7019 is a BBB-penetrable radioligand for brain imaging that target butyrylcholinesterase. TRV-7019 can be used for the diagnosis of an amyloid disease, multiple sclerosis, a brain tumor, or butyrylcholinesterase activity[1].
Product Specifications
CAS Number
2598164-15-7
UNSPSC
12352005
Target
Cholinesterase (ChE)
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease; Cancer
Assay Protocol
https://www.medchemexpress.com/trv-7019.html
Purity
99.64
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=NC(OC)=CC=C1)OCC2=CC=C(I)C=C2
Molecular Formula
C14H12INO3
Molecular Weight
369.15
References & Citations
[1]Sultan Darvesh, et al. Butyrylcholinesterase compounds and use in diseases of the nervous system. Patent WO2021026429A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BChE
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
C8orf30A Polyclonal Antibody, APC-Cy5.5 Conjugated
AMDHD2, ID (AMDHD2, Putative N-acetylglucosamine-6-phosphate deacetylase, Amidohydrolase domain-containing protein 2, GlcNAc 6-P deacetylase) (MaxLight 650) discontinued
